CerraCap Invests in Nephronomics to Advance AI-Driven Kidney Disease Discovery
COSTA MESA, Calif., April 21, 2026 /PRNewswire/ -- CerraCap Ventures investment in Nephronomics reflects strategic conviction of backing platforms that transform fragmented healthcare systems into predictive, precision-driven ecosystems. Nephronomics is a next-generation AI-bio precision...
View original →